Transcriptomic Signature and Functional Abnormalities of Bone Marrow Mesenchymal Stromal Cells Mediate Disease Progression of Myelodysplastic/Myeloproliferative Neoplasms

间充质干细胞 慢性粒单核细胞白血病 骨髓 造血 间质细胞 骨髓增生性肿瘤 癌症研究 川地34 生物 骨髓增生异常综合症 国际预后积分系统 转录组 祖细胞 骨髓纤维化 干细胞 免疫学 基因 遗传学 基因表达
作者
Zhiyong Poon,John F. Ouyang,Alice M.S. Cheung,Xianqun Fan,Vaidehi Krishnan,William Ying Khee Hwang,Hein Than
出处
期刊:Blood [Elsevier BV]
卷期号:142 (Supplement 1): 5618-5618
标识
DOI:10.1182/blood-2023-188426
摘要

Background Mesenchymal stromal cells (MSC) are vital components of the bone marrow (BM) microenvironment niche and regulate hematopoietic stem and progenitor cell (HSPC) activity. While HSPC harbor primary disease driver mutations, MSC in myelodysplastic syndrome and myeloproliferative neoplasm (MDS/MPN) have been shown to influence the emergence and selection of leukemic clones and disease progression. However, it remains unclear if there are specific functional characteristics or genetic signals of MSC that interact with HSPC at different stages of disease progression. We examined BM samples from MDS/MPN patients with high rate of leukemic transformation in less than 2 years (HR) versus those with stable disease for 5 years (SD), to investigate the phenotypic differentiation, functional characteristics, and transcriptomic profiles of MSC and the HSPC counterparts. Methods We obtained BM samples at diagnosis and follow-up from MDS/MPN patients including chronic myelomonocytic leukemia (CMML) treated at Singapore General Hospital. We studied 5 HR and 13 SD patient samples to compare against 5 healthy donor samples. MSC were derived in MesenCult-ACF media (StemCell Technologies), and phenotypic characterization was done after 1-2 passages. HSPC were subjected to co-culture expansion with MSC in MyeloCult-H5100 for 7 days, and long-term culture-initiating cell assays (LTC-IC) using MSC as feeder cells for 6 weeks. Total RNA extracted from MSC and HSPC were subjected to bulk and single-cell RNA sequencing (scRNA-Seq) (10X Genomics platform). Principal component analysis (PCA) was used for the uniform manifold approximation and projection (UMAP). Gene set enrichment analysis (GSEA) was performed on differentially expressed genes to examine canonical signaling pathways. Cellchat algorithm was applied to predict intercellular communication between MSC and HSPC using scRNA-Seq data. Results Baseline clinical variables for the international prognostic scoring system (IPSS) including age at diagnosis, myeloblast percentage and cytogenetics were not significantly different between HR and SD patients. Decreased osteogenic and chondrogenic differentiation, but relatively preserved adipogenic differentiation capacity was observed in all MDS/MPN MSC samples. A significantly lower yield of CD34+ CD38- primitive HSPC with myeloid skewing was observed in the co-culture experiments with MDS/MPN MSC, compared to healthy MSC. Pre-treatment of SD-MSC feeder with the hypomethylating agent 5-azacytidine improved the clonogenic potential of the corresponding co-cultured HSPC, but did not restore the HSPC colony yield with HR-MSC feeder. Unbiased PCA of bulk RNA-Seq data demonstrated greater clustering of HR-MSC, while SD and healthy MSC overlapped significantly. Genes associated with mesenchymal multipotency and differentiation (PODXL20, FOXQ122, SERPINA923) were generally downregulated in MDS/MPN MSC, likely attributed to promoter hypermethylation. Significant differential upregulation of CD74 and IL-6 expression was observed in HR-MSC, which suggested a uniquely enriched inflammatory signature. GSEA results showed that pathways associated with G2M cell cycle checkpoint, DNA repair, glycolysis, and response to azacytidine were suppressed in HR-MSC. UMAP on scRNA-Seq data of longitudinal MSC samples identified distinct clustering of HR-MSC at disease progression. Cell-cell interaction analysis predicted a strong communication between collagen-encoding genes (COL1A1 and COL1A2) in HR-MSC at diagnosis and CD44, a negative regulator of HSPC proliferation, and the interaction was further enhanced at disease progression (Figure 1). Ongoing analysis of downstream gene expression changes and secretome profile of HSPC in MDS/MPN MSC-based in-vivo scaffold models will be presented. Conclusion Together, our data point towards a degree of co-development and communication between MSC and HSPC during disease progression of MDS/MPN. Further characterization of the unique functional and transcriptomic signatures in MSC may help to optimize disease prognostication and identify novel therapeutic targets in MDS/MPN patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慈祥的白亦完成签到 ,获得积分10
刚刚
北风北风完成签到,获得积分10
刚刚
科研通AI65的应助被YunQiao采纳,获得10
1秒前
欢喜南霜完成签到,获得积分10
1秒前
1秒前
山复尔尔发布了新的文献求助10
2秒前
Lucas的应助被jixiyang采纳,获得10
3秒前
3秒前
香蕉觅云的应助被richardhipower采纳,获得10
3秒前
吴咩咩发布了新的文献求助10
4秒前
Cloud发布了新的文献求助10
4秒前
香蕉觅云的应助被程c采纳,获得10
5秒前
Hello的应助被萧小五采纳,获得10
5秒前
yaya完成签到 ,获得积分10
5秒前
冷酷的毛豆完成签到,获得积分20
5秒前
标致青雪发布了新的文献求助10
5秒前
5秒前
hmy发布了新的文献求助10
7秒前
kanraku的应助被哇爱学习采纳,获得10
7秒前
YunQiao完成签到,获得积分10
8秒前
8秒前
9秒前
10秒前
领导范儿的应助被YujieJin采纳,获得10
10秒前
yyds的应助被18756828852采纳,获得10
10秒前
可乐发布了新的文献求助10
10秒前
11秒前
Yancy完成签到 ,获得积分10
11秒前
超级无敌暴龙战士完成签到 ,获得积分10
11秒前
11秒前
12秒前
13秒前
ding的应助被干净的尔柳采纳,获得10
14秒前
科研通AI6.4的应助被yexing采纳,获得10
14秒前
Zza完成签到,获得积分10
14秒前
Opalite完成签到,获得积分10
16秒前
17秒前
17秒前
科研通AI6.2的应助被欣慰若菱采纳,获得150
17秒前
可乐完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192548
求助须知:如何正确求助?哪些是违规求助? 9579054
关于积分的说明 21863359
捐赠科研通 7792096
什么是DOI,文献DOI怎么找? 3436955
关于科研通互助平台的介绍 2560622
邀请新用户注册赠送积分活动 2483860